Abivax S.A. Income Statement

Income Statement Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 14.15M4.83M4.97M13.30M
Operating items
Research & Development 56.54M50.90M111.01M156.58M
Selling, General & Administrative 6.60M7.90M24.09M35.21M
Other Operating Expenses 14.37M6.92M6.36M
Operating Expenses 63.15M73.16M142.02M198.15M
Operating Income -48.99M-68.33M-137.05M-184.85M
EBIT -48.99M-68.33M-137.05M-184.85M
Non-operating items
Interest & Investment Income 2.97M11.72M8.08M14.67M
Non Operating Income -1.24M4.32M-21.91M-3.48M
Net income details
EBT -50.24M-64.02M-158.96M-188.33M
Profit After Tax -50.24M-64.02M-158.96M-188.33M
Income from Continuing Operations -50.24M-64.02M-158.96M-188.33M
Consolidated Net Income -50.24M-64.02M-158.96M-188.33M
Income towards Parent Company -50.24M-64.02M-158.96M-188.33M
Net Income towards Common Stockholders -50.24M-64.02M-158.96M-188.33M
Additional items
EPS (Basic) -3.25-3.35-3.69-2.99
EPS (Weighted Average and Diluted) -3.25-3.35-3.69-2.99
Shares Outstanding (Weighted Average) 42.55M62.87M62.93M
Shares Outstanding (Diluted Average) 18.29M20.12M46.34M67.37M
EBITDA -48.99M-68.33M-137.05M-184.85M
Interest Expenses 4.21M7.40M29.99M18.16M